NEW YORK (GenomeWeb) – Cancer informatics and precision medicine firm Tempus said today that it has raised $110 million in a Series E financing round.
Participants in the round included Baillie Gifford, funds and accounts managed by T. Rowe Price, Revolution Growth, New Enterprise Associates, and other existing investors.
As Handbag Small Yuncai Picture5 Backpack Multifunctional Womens Bags Waterproof Casual Tempus, based in Chicago, said that it will use the additional funds to grow operations and expand into new therapeutic areas and geographies.